Search

Your search keyword '"Jesudason, Shilpanjali"' showing total 377 results

Search Constraints

Start Over You searched for: Author "Jesudason, Shilpanjali" Remove constraint Author: "Jesudason, Shilpanjali"
377 results on '"Jesudason, Shilpanjali"'

Search Results

Catalog

Books, media, physical & digital resources

4. Perspectives of Caregivers on Access to Health Care for Children with CKD

12. Baseline Characteristics of Frailty and Disease Stage in Older People Living With CKD

13. Improving Diverse and Equitable Involvement of Patients and Caregivers in Research in CKD: Report of a Better Evidence and Translation–Chronic Kidney Disease (BEAT-CKD) Workshop

15. Baseline characteristics of participants in the NAVKIDS2 trial: a patient navigator program in children with chronic kidney disease

17. How Can Nurses Support Patients on Hemodialysis Who Experience Needle Fear? An Online Educational Intervention for Nephrology Nurses

19. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

25. Real Ways of Working Together: co‐creating meaningful Aboriginal community consultations to advance kidney care

26. Aboriginal patients driving kidney and healthcare improvements: recommendations from South Australian community consultations

27. Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

28. Glomerular diseases in pregnancy: pragmatic recommendations for clinical management

36. NAVKIDS2 trial: a multi-centre, waitlisted randomised controlled trial of a patient navigator intervention in children with chronic kidney disease — statistical analysis plan and update to the protocol

37. The Symptom Monitoring with Feedback Trial (SWIFT): protocol for a registry-based cluster randomised controlled trial in haemodialysis

41. WCN24-2160 SUBSTANTIAL SEX DIFFERENCES IN PERITONEAL DIALYSIS OUTCOMES: RESULTS FROM PDOPPS

45. Significant kidney disease in pregnancy: Feasibility and outcomes of a national population‐based study using the Australasian Maternity Outcomes Surveillance System.

46. Nephrology nurses' perspectives working with patients experiencing needle‐related distress.

49. Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial